18:29:07 EDT Thu 03 Jul 2025
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 41,327,425
Close 2025-01-14 C$ 0.03
Market Cap C$ 1,239,823
Recent Sedar Documents

Ndatalyze releases AI-based CMCP-5 anxiety tool

2025-01-14 18:01 ET - News Release

Mr. Jim Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTCQB:NDATF) ANNOUNCES AI-BASED CALIBRATION OF ITS ANXIETY ASSESSSMENT FORMULAS

Ndatalyze Corp. has released AI (artificial intelligence) based calibration of its CMCP-5 anxiety assessment algorithm. As with the previously announced depression algorithm, this development allows accurate assessments without real-time machine-learning processing, thereby simplifying migration to third party applications (such as electronic medical records) while reducing processing costs. The anxiety assessment algorithm and previously announced depression assessment algorithm are now being migrated to the Google Cloud. These developments will allow physicians and therapists to directly compare depression and anxiety predispositions/probabilities when coming to diagnostic and treatment decisions.

James Durward, president, commented: "Anxiety and depression are the top two mental disorders in the [United States] and Canada. These disorders commonly co-exist, often resulting in mis/overdiagnosis with follow-on misprescription and poor patient outcomes. The ability to differentiate between depression and anxiety is fundamental to better patient outcomes. This is one of the biggest problems in mental health, so it is our top priority."

The anxiety and depression algorithms referred to above are a subset of the corporation's CMCP-5 (formerly YMI) predictive mental condition suite.

About CMCP-5

CMCP-5 uses evidence-based, objective data from whole life experiences to predict individual mental states over time, and applies this knowledge toward a better understanding of how mental health develops and how to improve mental well-being. CMCP-5 combines expert-guided machine learning with a proprietary reference database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies and targeting key markets, CMCP-5 aligns societal impact with financial success.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.